1. Home
  2. PAHC vs BLND Comparison

PAHC vs BLND Comparison

Compare PAHC & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • BLND
  • Stock Information
  • Founded
  • PAHC 1946
  • BLND 2012
  • Country
  • PAHC United States
  • BLND United States
  • Employees
  • PAHC N/A
  • BLND N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • BLND EDP Services
  • Sector
  • PAHC Health Care
  • BLND Technology
  • Exchange
  • PAHC Nasdaq
  • BLND Nasdaq
  • Market Cap
  • PAHC 968.3M
  • BLND 925.5M
  • IPO Year
  • PAHC 2014
  • BLND 2021
  • Fundamental
  • Price
  • PAHC $29.49
  • BLND $3.41
  • Analyst Decision
  • PAHC Hold
  • BLND Buy
  • Analyst Count
  • PAHC 4
  • BLND 7
  • Target Price
  • PAHC $24.50
  • BLND $4.93
  • AVG Volume (30 Days)
  • PAHC 341.9K
  • BLND 1.9M
  • Earning Date
  • PAHC 08-27-2025
  • BLND 08-07-2025
  • Dividend Yield
  • PAHC 1.63%
  • BLND N/A
  • EPS Growth
  • PAHC 140.17
  • BLND N/A
  • EPS
  • PAHC 0.78
  • BLND N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • BLND $164,949,000.00
  • Revenue This Year
  • PAHC $28.13
  • BLND N/A
  • Revenue Next Year
  • PAHC $13.11
  • BLND $28.57
  • P/E Ratio
  • PAHC $37.79
  • BLND N/A
  • Revenue Growth
  • PAHC 19.12
  • BLND 15.07
  • 52 Week Low
  • PAHC $16.16
  • BLND $2.37
  • 52 Week High
  • PAHC $31.80
  • BLND $5.53
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 64.77
  • BLND 53.71
  • Support Level
  • PAHC $29.64
  • BLND $3.50
  • Resistance Level
  • PAHC $31.71
  • BLND $3.66
  • Average True Range (ATR)
  • PAHC 1.07
  • BLND 0.12
  • MACD
  • PAHC -0.01
  • BLND 0.02
  • Stochastic Oscillator
  • PAHC 69.12
  • BLND 66.67

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

Share on Social Networks: